Early predictors of improved long-term outcomes in first-line antiangiogenics plus chemotherapy (anti-ANG/CT) in metastatic colorectal cancer (mCRC): Analysis of individual patient (pt) data from the ARCAD database.

Authors

null

Everardo D. Saad

Dendrix Research, Sao Paulo, Brazil

Everardo D. Saad , Elisabeth Coart , Dirkje Willemien Sommeijer , Qian Shi , John Raymond Zalcberg , Tomasz Burzykowski , Jeffrey P. Meyers , Paulo Marcelo Hoff , J. Randolph Hecht , Herbert Hurwitz , Jolien Tol , Niall C. Tebbutt , Charles S. Fuchs , Eduardo Diaz-Rubio , John Souglakos , Alfredo Falcone , Fairooz F. Kabbinavar , Daniel J. Sargent , Aimery De Gramont , Marc E. Buyse

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 3578)

DOI

10.1200/jco.2014.32.15_suppl.3578

Abstract #

3578

Poster Bd #

41

Abstract Disclosures